Conquering Diseases

Study Of An Investigational Drug Combination For Advanced Non-Small Cell Lung Cancer

Description

Seeking men and women aged 18 and older whose non-small cell lung cancer has come back or has grown after receiving immunotherapy treatment and who are not a candidate for other biomarker-matched treatment studies for a study of an investigational drug combination.

Overview

Participants in this study will be randomly assigned to get either the standard therapy or the investigational drug combination.

What we're hoping for

We are studying whether the investigational drug combination helps the immune system fight cancer and extend life for people whose non-small cell lung cancer has come back or has grown after receiving immunotherapy treatment

Additional Information

ClinicalTrials.gov Identifier: NCT05096663

 Principal Investigator

William  Walsh, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989